A powerful advance in cancer-fighting medicine has achieved an extraordinary new milestone.

Chimeric Antigen Receptor (CAR) T cell therapy is an immunotherapy technique that involves taking a patient’s immune cells and genetically engineering them to become potent cancer-hunting predators.

The treatment has shown huge promise in helping patients treat cancer, although its effectiveness has mostly been limited to treating blood cancers, not solid tumors.